M
ORMP icon

Murchinson’s Oramed Pharmaceuticals ORMP Stock Holding History

Murchinson’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21M Sell
1,290,294
-25,000
-2% -$99.5K 0.86% 33
2026
Q1 		$4.47M Sell
1,315,294
-24,953
-2% -$84.7K 0.57% 32
2025
Q4 		$3.82M Sell
1,340,247
-411,312
-23% -$1.06M 0.61% 28
2025
Q3 		$4.62M Hold
1,751,559
– – 0.59% 25
2025
Q2 		$3.94M Sell
1,751,559
-200
-0% -$441 1.4% 13
2025
Q1 		$3.75M Buy
1,751,759
+800
+0% +$1.85K 0.2% 33
2024
Q4 		$4.24M Buy
1,750,959
+42,080
+2% +$100K 1.81% 9
2024
Q3 		$4.17M Buy
1,708,879
+8,889
+0.5% +$21.7K 1.13% 23
2024
Q2 		$4.37M Buy
1,699,990
+320,495
+23% +$762K 0.67% 25
2024
Q1 		$4.03M Buy
1,379,495
+329,495
+31% +$921K 0.34% 38
2023
Q4 		$2.43M Buy
+1,050,000
New +$2.24M 0.42% 25

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Murchinson's ORMP Position: Q2 2026 in Review

Murchinson reduced its Oramed Pharmaceuticals (ORMP) stake by 1.9% in Q2 2026, selling an estimated $99.5K and leaving 1,290,294 shares worth $6.21M. The position accounts for 0.86% of the portfolio, ranked #33.

Murchinson first reported a position in ORMP in Q4 2023 and has held it in 11 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Murchinson held 1,290,294 shares of Oramed Pharmaceuticals worth $6.21M as of Q2 2026.
  • Murchinson sold 25,000 Oramed Pharmaceuticals shares in Q2 2026, an estimated $99.5K.
  • Oramed Pharmaceuticals made up 0.86% of Murchinson's portfolio in Q2 2026, its #33 holding.
  • Murchinson first reported a position in Oramed Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Murchinson's 13F filing for Q2 2026, filed 14 Aug 2026.